A large analysis suggests that a multivariable risk assessment tool, called Stockholm3, can detect substantially more ...

A new study reveals a shocking jump in “biological age” among Gen-X, Millennials, and Gen-Z—and it might explain the rise in early-onset cancers.

InterVenn Biosciences, a life sciences company unlocking the value of glycoproteomics for the development of transformational healthcare solutions, and Aranscia, a global provider of award-winning ...

A risk model that combines a mammographic artificial intelligence (AI) risk score with polygenic and clinical risk scores ...

Data presented during ICCBH 2026 showed that improvements in tibial-femoral angle (TFA), a measure of lower extremity alignment, continued ...

Heart failure (HF) remains a pressing health concern, with rising prevalence globally. Subjectivity and ambiguity in the ...

Cancer is one of the leading causes of death and disability, affecting millions of working-age adults and their families each ...

A quantum-inspired AI approach can analyze millions of molecular features from small datasets, improving predictions, ...

PS, designed entirely by artificial intelligence, passed its first human safety trial at Cambridge — triggering ...

NetraMark Holdings Inc. (the "Company" or "NetraMark") , an artificial intelligence (AI) company that is transforming ...

We look at power, speed, calories, recovery, fuelling and more to compare a Tour de France rider's efforts to those of an ...

Ascendis Pharma A/S (Nasdaq: ASND) today announced that the latest data from its clinical development programs for the treatment of children with achondroplasia will be shared in an oral presentation ...